Metabolic tumor imaging using magnetic resonance spectroscopy

Research output: Contribution to journalArticle

Abstract

The adaptability and the genomic plasticity of cancer cells, and the interaction between the tumor microenvironment and co-opted stromal cells, coupled with the ability of cancer cells to colonize distant organs, contribute to the frequent intractability of cancer. It is becoming increasingly evident that personalized molecular targeting is necessary for the successful treatment of this multifaceted and complex disease. Noninvasive imaging modalities such as magnetic resonance (MR), positron emission tomography (PET), and single-photon emission computed tomography (SPECT) are filling several important niches in this era of targeted molecular medicine, in applications that span from bench to bedside. In this review we focus on noninvasive magnetic resonance spectroscopy (MRS) and spectroscopic imaging (MRSI) and their roles in future personalized medicine in cancer. Diagnosis, the identification of the most effective treatment, monitoring treatment delivery, and response to treatment are some of the broad areas into which MRS techniques can be integrated to improve treatment outcomes. The development of novel probes for molecular imagingin combination with a slew of functional imaging capabilitiesmakes MRS techniques, especially in combination with other imaging modalities, valuable in cancer drug discovery and basic cancer research.

Original languageEnglish (US)
Pages (from-to)26-41
Number of pages16
JournalSeminars in Oncology
Volume38
Issue number1
DOIs
StatePublished - Feb 2011

Fingerprint

Magnetic Resonance Spectroscopy
Neoplasms
Molecular Medicine
Molecular Probes
Precision Medicine
Tumor Microenvironment
Drug Discovery
Therapeutics
Stromal Cells
Single-Photon Emission-Computed Tomography
Cell Communication
Positron-Emission Tomography
Research

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

Metabolic tumor imaging using magnetic resonance spectroscopy. / Glunde, Kristine; Bhujwalla, Zaver M.

In: Seminars in Oncology, Vol. 38, No. 1, 02.2011, p. 26-41.

Research output: Contribution to journalArticle

@article{71c8b43ebdbb402b9be72538a3ba0d20,
title = "Metabolic tumor imaging using magnetic resonance spectroscopy",
abstract = "The adaptability and the genomic plasticity of cancer cells, and the interaction between the tumor microenvironment and co-opted stromal cells, coupled with the ability of cancer cells to colonize distant organs, contribute to the frequent intractability of cancer. It is becoming increasingly evident that personalized molecular targeting is necessary for the successful treatment of this multifaceted and complex disease. Noninvasive imaging modalities such as magnetic resonance (MR), positron emission tomography (PET), and single-photon emission computed tomography (SPECT) are filling several important niches in this era of targeted molecular medicine, in applications that span from bench to bedside. In this review we focus on noninvasive magnetic resonance spectroscopy (MRS) and spectroscopic imaging (MRSI) and their roles in future personalized medicine in cancer. Diagnosis, the identification of the most effective treatment, monitoring treatment delivery, and response to treatment are some of the broad areas into which MRS techniques can be integrated to improve treatment outcomes. The development of novel probes for molecular imagingin combination with a slew of functional imaging capabilitiesmakes MRS techniques, especially in combination with other imaging modalities, valuable in cancer drug discovery and basic cancer research.",
author = "Kristine Glunde and Bhujwalla, {Zaver M}",
year = "2011",
month = "2",
doi = "10.1053/j.seminoncol.2010.11.001",
language = "English (US)",
volume = "38",
pages = "26--41",
journal = "Seminars in Oncology",
issn = "0093-7754",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Metabolic tumor imaging using magnetic resonance spectroscopy

AU - Glunde, Kristine

AU - Bhujwalla, Zaver M

PY - 2011/2

Y1 - 2011/2

N2 - The adaptability and the genomic plasticity of cancer cells, and the interaction between the tumor microenvironment and co-opted stromal cells, coupled with the ability of cancer cells to colonize distant organs, contribute to the frequent intractability of cancer. It is becoming increasingly evident that personalized molecular targeting is necessary for the successful treatment of this multifaceted and complex disease. Noninvasive imaging modalities such as magnetic resonance (MR), positron emission tomography (PET), and single-photon emission computed tomography (SPECT) are filling several important niches in this era of targeted molecular medicine, in applications that span from bench to bedside. In this review we focus on noninvasive magnetic resonance spectroscopy (MRS) and spectroscopic imaging (MRSI) and their roles in future personalized medicine in cancer. Diagnosis, the identification of the most effective treatment, monitoring treatment delivery, and response to treatment are some of the broad areas into which MRS techniques can be integrated to improve treatment outcomes. The development of novel probes for molecular imagingin combination with a slew of functional imaging capabilitiesmakes MRS techniques, especially in combination with other imaging modalities, valuable in cancer drug discovery and basic cancer research.

AB - The adaptability and the genomic plasticity of cancer cells, and the interaction between the tumor microenvironment and co-opted stromal cells, coupled with the ability of cancer cells to colonize distant organs, contribute to the frequent intractability of cancer. It is becoming increasingly evident that personalized molecular targeting is necessary for the successful treatment of this multifaceted and complex disease. Noninvasive imaging modalities such as magnetic resonance (MR), positron emission tomography (PET), and single-photon emission computed tomography (SPECT) are filling several important niches in this era of targeted molecular medicine, in applications that span from bench to bedside. In this review we focus on noninvasive magnetic resonance spectroscopy (MRS) and spectroscopic imaging (MRSI) and their roles in future personalized medicine in cancer. Diagnosis, the identification of the most effective treatment, monitoring treatment delivery, and response to treatment are some of the broad areas into which MRS techniques can be integrated to improve treatment outcomes. The development of novel probes for molecular imagingin combination with a slew of functional imaging capabilitiesmakes MRS techniques, especially in combination with other imaging modalities, valuable in cancer drug discovery and basic cancer research.

UR - http://www.scopus.com/inward/record.url?scp=79952154676&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952154676&partnerID=8YFLogxK

U2 - 10.1053/j.seminoncol.2010.11.001

DO - 10.1053/j.seminoncol.2010.11.001

M3 - Article

C2 - 21362514

AN - SCOPUS:79952154676

VL - 38

SP - 26

EP - 41

JO - Seminars in Oncology

JF - Seminars in Oncology

SN - 0093-7754

IS - 1

ER -